Analyst Ratings

Upgrades, downgrades, and outlook changes from major analysts.

Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.

Articles

3,519 total articles

Wedbush Lifts GlobalFoundries Price Target to $50, Cites Strength in Mature Foundry and AI-Adjacent Markets

Wedbush Lifts GlobalFoundries Price Target to $50, Cites Strength in Mature Foundry and AI-Adjacent Markets

Wedbush raised its price target for GlobalFoundries Inc. (GFS) to $50 from $40 while keeping a Neutral rating, pointing to better-than-expected conditions in the mature foundry market and expanding opportunities tied to AI-related power and networking markets. The chipmaker recently posted Q4 2025 results that exceeded expectations, and other broke…

BofA Elevates Huntington Ingalls to Neutral, Increases Price Target to $400 on Stronger Shipbuilding Outlook

BofA Elevates Huntington Ingalls to Neutral, Increases Price Target to $400 on Stronger Shipbuilding Outlook

BofA Securities upgraded Huntington Ingalls Industries from Underperform to Neutral and lifted its price target to $400 from $300, citing stronger shipbuilding sector fundamentals and a higher relative price-to-free-cash-flow multiple for 2027. The move comes as HII reports improving momentum and recent quarterly results that beat expectations, eve…

Clear Street Upholds Buy on Century Therapeutics at $6.60, Cites Lead Cell Therapy for Type 1 Diabetes

Clear Street Upholds Buy on Century Therapeutics at $6.60, Cites Lead Cell Therapy for Type 1 Diabetes

Clear Street has reiterated a Buy rating and a $6.60 price target on Century Therapeutics (IPSC), pointing to strong potential for CNTY-813 as a cell therapy aimed at treating type 1 diabetes. The firm emphasized Century’s Allo-Evasion hypoimmune edits as a competitive advantage and noted early competitive data supporting the approach. Recent finan…

Oppenheimer Maintains Outperform on Aurora Innovation, Flags Large Upside Despite Weaker 2026 Guidance

Oppenheimer Maintains Outperform on Aurora Innovation, Flags Large Upside Despite Weaker 2026 Guidance

Oppenheimer has reiterated an Outperform rating and maintained a $15.00 price target on Aurora Innovation Inc (NASDAQ:AUR), even after the company issued 2026 revenue guidance below consensus and signaled higher-than-expected cash burn. The price target implies roughly 244% upside from AUR’s trading level of $4.36, amid recent volatility in the sha…

William Blair Upholds Outperform on ViaSat After Southwest Picks Starlink for Older Jets

William Blair Upholds Outperform on ViaSat After Southwest Picks Starlink for Older Jets

William Blair has kept an Outperform rating on ViaSat after Southwest Airlines said it will install SpaceX’s Starlink on more than 300 aircraft this year. The firm says the Starlink rollout replaces Anuvu systems on older planes and does not affect ViaSat equipment on Southwest’s existing fleet; Southwest will continue to fit ViaSat systems on all …

Barclays Cuts Unity Software Price Target to $28, Cites Ongoing Uncertainties Despite Operational Strength

Barclays Cuts Unity Software Price Target to $28, Cites Ongoing Uncertainties Despite Operational Strength

Barclays trimmed its price target for Unity Software (NYSE:U) to $28 from $35 while keeping an Equalweight rating. The bank cited improving AI-driven world models and advertising scale potential, but said valuation upside may be constrained until key uncertainties are resolved. Unity posted revenue and EBITDA above consensus, reported robust traili…

Truist Lifts Genuine Parts Price Target to $162, Citing Industrial Momentum and Automotive Resilience

Truist Lifts Genuine Parts Price Target to $162, Citing Industrial Momentum and Automotive Resilience

Truist Securities increased its 12-month price target for Genuine Parts Company (GPC) to $162 from $146 and kept a Buy rating, highlighting traction in the industrial segment and ongoing support for the automotive business. The stock is trading just shy of its 52-week high after posting strong year-to-date and one-year returns. Other brokerages hav…